• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Chronic conventional disease-modifying anti-rheumatic drugs masking severe SARS-CoV-2 manifestations in an elderly rheumatic patient.

作者信息

Sagnelli Caterina, Gentile Valeria, Tirri Rosella, Macera Margherita, Cappabianca Salvatore, Ciccia Francesco, Coppola Nicola

机构信息

Department of Mental Health and Public Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.

Department of Scienze Mediche Traslazionali, University of Campania "Luigi Vanvitelli", Naples, Italy.

出版信息

J Infect. 2020 Dec;81(6):979-997. doi: 10.1016/j.jinf.2020.05.043. Epub 2020 May 29.

DOI:10.1016/j.jinf.2020.05.043
PMID:32474034
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7256595/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/505e/7256595/069d161052dc/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/505e/7256595/f62e13e64c7a/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/505e/7256595/069d161052dc/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/505e/7256595/f62e13e64c7a/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/505e/7256595/069d161052dc/gr2_lrg.jpg

相似文献

1
Chronic conventional disease-modifying anti-rheumatic drugs masking severe SARS-CoV-2 manifestations in an elderly rheumatic patient.慢性传统改善病情抗风湿药物掩盖了一名老年风湿性疾病患者的严重新型冠状病毒肺炎表现。
J Infect. 2020 Dec;81(6):979-997. doi: 10.1016/j.jinf.2020.05.043. Epub 2020 May 29.
2
Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs.2019年冠状病毒病（COVID-19）与抗风湿药物
Rheumatol Int. 2020 May;40(5):825-826. doi: 10.1007/s00296-020-04570-z. Epub 2020 Mar 30.
3
National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD.德国炎症性风湿病（IRD）患者感染 SARS-CoV-2 的国家登记处（ReCoVery）：了解 IRD 患者 SARS-CoV-2 感染临床病程的快速可靠知识的宝贵手段。
RMD Open. 2020 Sep;6(2). doi: 10.1136/rmdopen-2020-001332.
4
Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies.接受生物和合成靶向治疗的风湿性疾病患者中COVID-19的临床特征和结局
Ann Rheum Dis. 2020 Jul;79(7):988-990. doi: 10.1136/annrheumdis-2020-217948. Epub 2020 Jun 5.
5
Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry.风湿性疾病患者因 COVID-19 住院的相关特征：来自 COVID-19 全球风湿病联盟医生报告登记处的数据。
Ann Rheum Dis. 2020 Jul;79(7):859-866. doi: 10.1136/annrheumdis-2020-217871. Epub 2020 May 29.
6
Clinical course, severity and mortality in a cohort of patients with COVID-19 with rheumatic diseases.一组患有风湿性疾病的COVID-19患者的临床病程、严重程度和死亡率。
Ann Rheum Dis. 2020 Dec;79(12):1659-1661. doi: 10.1136/annrheumdis-2020-218054. Epub 2020 Jun 30.
7
Rheumatologic Manifestations of Post SARS-CoV-2 Infection: A Case Series.新冠病毒感染后风湿表现：病例系列。
Curr Rheumatol Rev. 2022;18(4):346-351. doi: 10.2174/1573397118666220211155716.
8
Use of conventional synthetic and biologic disease-modifying anti-rheumatic drugs in patients with rheumatic diseases contracting COVID-19: a single-center experience.在感染新型冠状病毒肺炎的风湿性疾病患者中使用传统合成及生物改善病情抗风湿药物：单中心经验
Rheumatol Int. 2021 May;41(5):903-909. doi: 10.1007/s00296-021-04818-2. Epub 2021 Mar 3.
9
Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy.生物制剂治疗的风湿性疾病合并冠状病毒感染的推荐建议。
J Autoimmun. 2020 May;109:102442. doi: 10.1016/j.jaut.2020.102442. Epub 2020 Apr 2.
10
Biological agents for rheumatic diseases in the outbreak of COVID-19: friend or foe?COVID-19 疫情期间的风湿性疾病生物制剂：是敌是友？
RMD Open. 2021 Jan;7(1). doi: 10.1136/rmdopen-2020-001439.

引用本文的文献

1
Characteristics of COVID-19 Infection in a Hospitalized Autoimmune Hepatitis Patient.一名住院自身免疫性肝炎患者的新型冠状病毒肺炎感染特征
Pathogens. 2022 Sep 16;11(9):1054. doi: 10.3390/pathogens11091054.
2
COVID-19 and Genitourinary Tract: A Retrospective Study in the Tertiary Care Center.新型冠状病毒肺炎与泌尿生殖道：三级医疗中心的一项回顾性研究
Cureus. 2022 Jul 22;14(7):e27153. doi: 10.7759/cureus.27153. eCollection 2022 Jul.
3
Prevention of HBV Reactivation in Hemato-Oncologic Setting during COVID-19.新冠疫情期间血液肿瘤领域乙肝病毒再激活的预防
Pathogens. 2022 May 11;11(5):567. doi: 10.3390/pathogens11050567.
4
Renal involvement in COVID-19: focus on kidney transplant sector.COVID-19 中的肾脏受累：重点关注肾移植领域。
Infection. 2021 Dec;49(6):1265-1275. doi: 10.1007/s15010-021-01706-6. Epub 2021 Oct 5.
5
Effects of laser acupuncture tele-therapy for rheumatoid arthritis elderly patients.激光针灸远程治疗对老年类风湿关节炎患者的影响。
Lasers Med Sci. 2022 Feb;37(1):499-504. doi: 10.1007/s10103-021-03287-0. Epub 2021 Mar 19.
6
SARS-CoV-2 infection affects the lower urinary tract and male genital system: A systematic review.SARS-CoV-2 感染影响下尿路和男性生殖系统：系统综述。
J Med Virol. 2021 May;93(5):3133-3142. doi: 10.1002/jmv.26883. Epub 2021 Mar 1.
7
Cardiovascular System in COVID-19: Simply a Viewer or a Leading Actor?新冠病毒肺炎中的心血管系统：仅仅是旁观者还是主角？
Life (Basel). 2020 Aug 27;10(9):165. doi: 10.3390/life10090165.
8
Management of SARS-CoV-2 pneumonia.SARS-CoV-2 肺炎的管理。
J Med Virol. 2021 Mar;93(3):1276-1287. doi: 10.1002/jmv.26470. Epub 2020 Oct 10.
9
Current Status of Laboratory Diagnosis for COVID-19: A Narrative Review.新型冠状病毒肺炎实验室诊断的现状：一篇综述
Infect Drug Resist. 2020 Aug 3;13:2657-2665. doi: 10.2147/IDR.S264020. eCollection 2020.
10
Clinical Presentation of COVID-19: Case Series and Review of the Literature.COVID-19 的临床特征：病例系列与文献回顾。
Int J Environ Res Public Health. 2020 Jul 14;17(14):5062. doi: 10.3390/ijerph17145062.